Dow Up0.76% Nasdaq Up0.69%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE
129.13 Up 1.11(0.87%) Oct 24, 4:01PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.0
Mean Recommendation (last week):3.4
Change:-0.4

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:52.38
Median Target:50.00
High Target:75.00
Low Target:34.50
No. of Brokers:4

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 30, 2013FBR CapitalInitiated Outperform
Jun 10, 2013CRT CapitalUpgradeHoldBuy
Feb 22, 2013Aegis CapitalInitiated Buy
Feb 5, 2010Jefferies & CoInitiated Buy
Jul 9, 2009Leerink SwannDowngradeOutperformMkt Perform
Jun 9, 2009WachoviaDowngradeMkt PerformUnderperform
May 14, 2009Ladenburg ThalmannInitiated Neutral
May 14, 2009SoleilInitiated Sell
Mar 24, 2009Leerink SwannInitiated Outperform
Oct 28, 2008Brean MurrayInitiated Sell

More Upgrades & Downgrades for VRX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy6666
Buy9989
Hold2221
Underperform1110
Sell0000

Data provided by Thomson/First Call


Currency in USD.